Navigation Links
PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
Date:1/4/2008

BOSTON, Jan. 4 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) will release Second Quarter Fiscal Year 2008 financial results on Wednesday, January 23, 2008 after the close of the stock market. The announcement will be available on PAREXEL's website at http://www.parexel.com and on the PR Newswire website at http://www.prnewswire.com.

PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, January 24, 2008 to discuss the results. To access the webcast, visit PAREXEL's website at http://www.parexel.com, click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (612) 332-0107 and ask to join PAREXEL's Second Quarter Fiscal Year 2008 conference call.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical developm
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Washington, USA (PRWEB) March 29, 2015 ... and the United States and plenary talks by four ... SPIE Optics + Optoelectronics next month in ... technical presentations in 17 conferences alongside a two-day exhibition. ... and photonics , the event will run 13-16 April ...
(Date:3/30/2015)... 2015 Richmond Pharmacology nimmt ... Pharmacology ist das erste Zentrum weltweit, das in ... Hospital in London in ... Studienversuche an einem Patienten begonnen hat. Das Therapeutikum ... entwickelt (ATTR), einer seltenen Herz- und Nervenkrankheit. ...
(Date:3/29/2015)... 29, 2015  Caris Life Sciences® today ... small cell cervical cancer (SCCC) that shows ... the company,s panomic, comprehensive tumor profiling service, identified ... may explain sensitivities and resistance to common ... certain biomarkers may guide treatment strategies in ...
(Date:3/27/2015)... Cranston, RI (PRWEB) March 27, 2015 ... for the promotion of hair regrowth in adult ... Savin classifications I-II or Norwood Hamilton classifications of IIa-V ... In an industry plagued by products that over-promise and ... the Capillus272Pro™, renewing faith and confidence among more than ...
Breaking Biology Technology:Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2
... India remain hot, as VCs face more competition from private ... ... Venture capitalists will largely,direct their investments to the greentech and biotech ... for venture,funds, according to a recent survey by the U.S. audit, ...
... CRY ),a biomaterials, medical device and tissue processing company, ... results will be,released on Thursday, February 21, 2008. The ... 10:00 a.m. Eastern Time, February,21, 2008, to discuss the ... Steven G. Anderson, president and chief executive officer of,CryoLife, ...
... WALTHAM, Mass., Jan. 31 Repligen Corporation,(Nasdaq: ... Chief,Executive Officer, Walter C. Herlihy, Ph.D., will host a ... 11:00 a.m. EST, to report,third quarter fiscal year 2008 ... Company., This call is being webcast by Thomson/CCBN ...
Cached Biology Technology:Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 3CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results 2Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results 2Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results 3
(Date:3/24/2015)... 24, 2015   NexID Biometrics LLC, whose ... needs, today announced the beginning of shipments of version ... The company, based in Potsdam, N.Y. ... Connect:ID Expo, which began here today at the Walter ... 2.0 of its SDK boosts the accuracy rate range ...
(Date:3/23/2015)... LOS ANGELES , March 23, 2015  In ... in Federal fraud case conviction losses. This figure accounts ... fraud, which, according to The Nilson Report, exceeds $11 ... an investigative tool after a crime has occurred. Investor ... Agent and polygraph expert Joe Paolella partnered ...
(Date:3/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces its biometric payment ... products featured in 2015 "I Want That" International CES ... on the DIY Network.   DIY,s "I ... , site of the 2015 International CES for a ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... Liverpool are developing a new plant-based product that could replace fishmeal, ... at a time when more than 90% of EU waters are ... to satisfy consumer need for fish in an expanding human population, ... 1.9 million tonnes by 2035. Currently farmed fish, such ...
... , AURORA, Colo. (May 14, 2012) - Why does ... published by a University of Colorado School of Medicine researcher ... anorexic women and desensitized in obese women. The findings also ... involved in addictions. Guido Frank, MD, assistant professor ...
... out scientifically valid virtual experiments. The method yields insights ... to research from the University of Gothenburg, Sweden. ... from the Swedish town of Lysekil for one year. ... Inquiry to Insight., Using scientific data provided by the ...
Cached Biology News:New product to replace fishmeal could help prevent global food shortage 2Real science in virtual school labs 2
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
Mouse monoclonal [RIZ1723] to PRDM2/RIZ...
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
Mouse monoclonal [1241] to Parainfluenza Virus type 2...
Biology Products: